- Research article
- Open Access
- Open Peer Review
This article has Open Peer Review reports available.
Three-year multicenter surveillance of community-acquired listeria monocytogenes meningitis in adults
- Rosario Amaya-Villar1Email author,
- Emilio García-Cabrera2, 3,
- Elena Sulleiro-Igual4,
- Pedro Fernández-Viladrich5,
- Dionisi Fontanals-Aymerich6,
- Pilar Catalán-Alonso7,
- Carlos Rodrigo-Gonzalo de Liria8,
- Ana Coloma-Conde9,
- Fabio Grill-Díaz10,
- Antonio Guerrero-Espejo11,
- Jerónimo Pachón3, 12 and
- Guillén Prats-Pastor4
© Amaya-Villar et al; licensee BioMed Central Ltd. 2010
Received: 7 June 2010
Accepted: 11 November 2010
Published: 11 November 2010
Listeria monocytogenes is the third most frequent cause of bacterial meningitis. The aim of this study is to know the incidence and risk factors associated with development of acute community-acquired Lm meningitis in adult patients and to evaluate the clinical features, management, and outcome in this prospective case series.
A descriptive, prospective, and multicentric study carried out in 9 hospitals in the Spanish Network for Research in Infectious Diseases (REIPI) over a 39-month period. All adults patients admitted to the participating hospitals with the diagnosis of acute community-acquired bacterial meningitis (Ac-ABM) were included in this study. All these cases were diagnosed on the basis of a compatible clinical picture and a positive cerebrospinal fluid (CSF) culture or blood culture. The patients were followed up until death or discharge from hospital.
Two hundred and seventy-eight patients with Ac-ABM were included. Forty-six episodes of Lm meningitis were identified in 46 adult patients. In the multivariate analysis only age (OR 1.026; 95% CI 1.00-1.05; p = 0.042), immunosupression (OR 2.520; 95% CI 1.05-6.00; p = 0.037), and CSF/blood glucose ratio (OR 39.42; 95% CI 4.01-387.50; p = 0.002) were independently associated with a Lm meningitis. The classic triad of fever, neck stiffness and altered mental status was present in 21 (49%) patients, 32% had focal neurological findings at presentation, 12% presented cerebellum dysfunction, and 9% had seizures. Twenty-nine (68%) patients were immunocompromised. Empirical antimicrobial therapy was intravenous ampicillin for 34 (79%) of 43 patients, in 11 (32%) of them associated to aminoglycosides. Definitive ampicillin plus gentamicin therapy was significantly associated with unfavourable outcome (67% vs 28%; p = 0.024) and a higher mortality (67% vs 32%; p = 0.040).The mortality rate was 28% (12 of 43 patients) and 5 of 31 (16.1%) surviving patients developed adverse clinical outcome.
Elderly or immunocompromised patients, and a higher CSF/blood glucose ratio in patients with Ac-ABM must alert clinicians about Lm aetiology. Furthermore, we observed a high incidence of acute community-acquired Lm meningitis in adults and the addition of aminoglycosides to treatment should be avoid in order to improve the patients' outcome. Nevertheless, despite developments in intensive care and antimicrobial therapy, this entity is still a serious disease that carries high morbidity and mortality rates.
Listeria monocytogenes (Lm) is a Gram-positive, facultative anaerobic bacterium that primarily causes sepsis and meningitis  in either immunocompromised or immunocompetent hosts [2, 3]. As a foodborne pathogen, it has emerged as a significant public health problem and has caused several epidemics in the United States and Europe. Community-acquired Lm meningitis is a serious and life-threatening disease. The estimated incidence is 0.2 cases per 100.000 adults per year in developed countries . Lm is the third most frequent cause of community-acquired bacterial meningitis, after Streptococcus pneumoniae and Neisseria meningitidis aetiologies, due to the vaccine-related decline in Haemophilus influenzae type b meningitis . This entity occurs mainly in immunocompromised patients, newborns, and elderly individuals , although previously healthy adults can be affected as well . Even with appropriate antibiotic therapy, this entity has a high morbidity and mortality (24%-62%) [2–4, 6–8].
In this report, we set out to study the incidence and risk factors associated with development of acute community-acquired Lm meningitis in adult patients and to evaluate the clinical features, management, and outcome in this prospective case series.
This is a prospective multicenter observational study carried out in 9 Spanish hospitals. All these hospitals are large institutions with teaching accreditation. The study was conducted over a 39-month period. All patients over 14 years old admitted to the participating hospitals with the diagnosis of acute community-acquired bacterial meningitis (Ac-ABM) were included in this study. The Ethical committees approved the study and did not require informed consent from the patient.
One investigator at each hospital prospectively recorded variables of all Ac-ABM in a previously designed database collecting data on patients' demography, clinical antecedents, symptoms and signs at admission, laboratory findings, clinical course, treatment, and outcome. Episodes of Ac-ABM were diagnosed on the basis of compatible clinical picture and at least 1 of the following cerebrospinal fluid (CSF) findings: CSF polymorphonuclear (PMN) pleocytosis [white blood cells (WBC) count >10/μl, 90% neutrophils, hipoglycorrachia <40 mg/dL or CSF/blood glucose ratio <40%, increased protein level >1 g/L, a positive CSF Gram's stain or culture, and/or positive blood cultures. When the CSF Gram's stain and blood and CSF cultures were negative, meningitis of unknown aetiology was recorded. Meningitis was considered to be community-acquired whenever a patient had not been previously treated in a hospital. If the patient had been previously admitted, Ac-ABM was diagnosed whenever the onset of the disease occurred 2 weeks after discharge or after 4 weeks if the patient had undergone surgery .
Lm meningitis was diagnosed in those patients with Ac-ABM in whom Lm was isolated in the CSF, blood culture, or both. Serotyping Lm was done using specific antisera, as described elsewhere .
Patients were considered immunocompromised if they were receiving immunosuppressive therapy and/or had haematological and solid malignancy, connective tissue disease, diabetes mellitus, alcoholism, asplenia, liver cirrhosis, end-stage renal disease, or HIV infection . Patients were considered elderly when they were 60 years or older.
The classic triad was defined when fever, neck stiffness and change in mental status were present. Hyponatremia was defined as a plasma sodium concentration <135 mmol/L . Focal neurological deficit was diagnosed when aphasia, monoparesis, hemiparesis or cranial nerve palsies were present at admission or during hospitalisation. Cerebellum dysfunction was diagnosed in patients with nystagmus, dysarthria, or limb and gait ataxia.
Time to admission was defined as the appearance of symptoms to admission to the hospital. Patients with impairment of consciousness, neurological deficits, or seizures, underwent cranial computed tomography (CT) before lumbar puncture.
Empiric antibiotic therapy was defined as any parenteral antibiotic capable of crossing the blood-brain barrier, administered for the purpose of treating bacterial meningitis . In the case of Lm meningitis, intravenous administration of penicillin, ampicillin, amoxicillin/clavulanic acid, piperacillin/tazobactam, a carbapenem, moxifloxacin or trimethoprim-sulfamethoxazole was considered adequate empirical therapy. During the follow up performance of a brain CT or the administration of adjunctive therapy (corticosteroids and/or phenytoin) were left for the physician in charge to decide.
All patients were followed up until death or hospital discharge. At discharge, all patients underwent a neurological examination, and outcome was measured according to the Glasgow Outcome Scale . A score of 1 on this scale indicates death; a score of 2, a vegetative state; a score of 3, severe disability; a score of 4, moderate disability; and a score of 5, mild or no disability. A favourable outcome was defined as a score of 5, and an unfavourable outcome was defined as a score of 1-4.
For the statistical analysis the SPSS 16.0 software package was used. Univariate analysis of variables from the entire population was performed using unpaired student's t-test for parametric continuous variables after correction for equality of variance (Levene's test), U Mann-Whitney test for non parametric continuous variables, and Pearson's chi-square test or Fisher's exact test for categorical variables. Statistical significance was considered when p <0.05. All p values were two-sided. Furthermore, a multivariate using logistic regression analysis was used to identify independent associations with Lm meningitis with results presented as Odds-Ratio (OR) and the 95% confidence intervals (95% CI). Finally, a univariate analysis comparing immunocompromised and immunocompetent patients with Lm meningitis was performed as previously indicated.
Aetiologies in 278 episodes of acute community-acquired bacterial meningitis in adults
Comparison of episodes of acute community-acquired Lm meningitis versus other aetiologies
Listeria monocytogenes (n = 43)
Other agents (n = 232)
Age (median ± IQR)
69 ± 30
56 ± 33
24 (56) d
Classic Triad a
GCS b at admission (median ± IQR)
13 ± 4
12 ± 4
Focal neurological deficit
Duration of symptoms in hours (median ± IQR)
70 ± 53
48 ± 53
WBC count CSF c (median ± IQR)
550 ± 2480
2860 ± 9380
CSF neutrophils ( median±IQR)
70 ± 59
90 ± 13
CSF/blood glucose (median ± IQR)
0.26 ± 0.24
0.09 ± 0.26
Protein level g/L ( median ± IQR)
2.0 ± 1.96
3.68 ± 5.53
Characteristics of patients with acute community-acquired Lm meningitis
Number of patients
Age (median ± IQR)
69 ± 30
69.5 ± 32
64.5 ± 23
Elderly (60 years or older)
Antibiotic therapy before admission b
Median time to admission (hours)
Time to admission > 48 h
Symptoms at presentation
Temperature ≥ 38°C
Glasgow Coma Scale at admission (median ± IQR)
13 ± 3
13 ± 5
13 ± 1
Classic Triad c
Focal neurological deficit
Cranial nerve palsies
Large nerve palsies
Indexes of CSFd inflammation
WBC count (median ± IQR)
550 ± 2400
936 ± 3610
310 ± 520
< 100 cells/mL
> 999 cells/mL
Protein level,g/L (median ± IQR)
2.4 ± 2.7
2.39 ± 2.26
2.88 ± 3.16
Protein level > 2 g/L
% PMN (median ± IQR)
70 ± 59
70 ± 62
65 ± 48
CSF/blood glucose (median ± IQR)
0.26 ± 0.23
0.27 ± 0.25
0.22 ± 0.23
CSF Gram stain
Positive CSF culture e
Positive blood cultures
Blood analytical findings
WBC count (109/L, (median ± IQR)
12 ± 10
10 ± 11
15 ± 5
Platelets (109/L, median ± IQR)
182 ± 75
161 ± 87
193 ± 70
Sodium (mEq/L, median ± IQR)
135.1 ± 4.9
134.2 ± 5
136.9 ± 3.8
Unfavorable outcome (GOSf<4)
In our series, in patients with Lm meningitis, fever was the most common symptom (91%). The majority of patients also had altered mental status at presentation, while headache was present in nearly half the patients. The classic triad of fever, neck stiffness and altered mental status was present in 21 (49%) patients; however, almost all patients (95%) had at least 1 or more of these symptoms. Thirty-two percent of the patients had focal neurological findings at presentation, 12% presented cerebellum dysfunction, and 9% had seizures. The most frequent focal neurological finding was cranial nerve palsies. The median duration of symptoms before admission to the hospital was two days. Immunocompromised patients had a lower incidence of the classic triad (45% vs. 71%; p = 0.039), headache (59% vs 85%; p = 0.076), and focal neurological deficit at presentation (28% vs 43%; p = 0.317) as compared with immunocompetent patients with acute community-acquired Lm meningitis.
Thirty-nine (91%) patients underwent CT in the emergency department. In 30 of 39 (77%), there were no abnormalities associated with the listerial infection. In the remaining 9 (23%) patients, the most common findings were focal lesions and/or hydrocephalus. All patients with hydrocephalus were treated neurosurgically.
Lumbar puncture was performed in all patients. CSF findings are outlined in Table 3. There was no relation between low CSF leukocyte count and age or immunocompromise. The most frequently found serotype was the 4b in 23 (82%) of 28 cases.
Empirical antimicrobial therapy was intravenous ampicillin (2 g every four hours) for 34 (79%) of 43 patients, in 11 (32%) of them combined with aminoglycosides. The rest of six patients received trimethoprim-sulfamethoxazole therapy in two cases and meropenem in the other four cases as empirical antibiotic treatment. Three patients that did not received appropiated empirical treatment receiving ceftriaxone plus vancomycin. Twenty-one patients (49%) received adjunctive therapy with dexamethasone; in 14 cases, the first dose was given previously or concomitantly to the first antibiotic dose, and eleven patients received phenytoin. There were no major side-effects of dexamethasone therapy (gastro-intestinal bleeding, hyperglycemia).
Description of patients with acute community-acquired Lm meningitis who survivied or died
Survivors n = 31
Non-Survivors n = 12
Age (median ± IQR)
67 ± 26
71 ± 43
GCSb at presentation (median ± IQR)
13 ± 11
13 ± 8
WBC > 999 cells/mL
Protein level g/L (median ± IQR)
2.1 ± 4.4
CSFd/blood glucose ratio (median ± IQR)
0.27 ± 0.24
0.18 ± 0.21
Empirical Ampicilllin + gentamicin therapy
Definitive Ampicillin + gentamicin therapy
Dexamethasone concomitant to antibiotic
Early administration of adequate antimicrobial therapy is the cornerstone of treatment in patients with meningitis. Despite developments in antimicrobial agents, Lm meningitis is still a serious disease that carries high morbidity and mortality rates. A relevant aspect in this study is the prospective inclusion of adult patients with acute community-acquired Lm meningitis, to evaluate risk factors associated with Lm aetiology which should contribute to early appropriate antimicrobial therapy of this serious and life-threatening disease. Thus, in a large cohort of patients with Ac-ABM, our study reveals that elderly, immunocompromised patients, and a higher CSF/blood glucose ratio were independently associated with isolation of Lm as the responsible pathogen.
In our own series, the incidence of acute community-acquired Lm meningitis in adults was 16.5% (46/278). Previously, in a multicenter study  conducted in the United States, the authors reported that Lm accounted for 8% of the cases of bacterial meningitis. Other studies from Europe and North America have reported incidences of 5%-10% or more among all episodes of Ac-ABM among adults [15–18]. Over a 36-year period, Durand et al. described that Lm accounted for 11% of the episodes of Ac-ABM in adults . The probable increase in the incidence may be attributed to longer life expectancy, changes in diet or food processing, and the higher number and longer survival of immunocompromised people .
On the other hand, symptoms and signs of patients presenting with Lm meningitis were not different from those found in the general population of patients with Ac-ABM, according to previous studies .
The CSF profile in patients with Listeria infection revealed significantly fewer WBC and lower protein concentrations than patients with infection due to other pathogens, and a trend towards less hypoglycorrhachia and a lower percentage of PMNs. However, these findings do not apply to all cases . In the appropriate clinical situation, clinicians should not exclude Lm based on the degree of pleocytosis, the percentage of PMNs, or the concentration of glucose or protein in the CSF.
The experience in the present series suggests that the Gram stain is negative in two-thirds of the cases of Lm meningitis, and may be misleading in many of the remaining cases. Clinicians should be aware of these difficulties, inform the microbiology department when they suspect this pathogen, and not rule out Lm based on Gram stain alone. Furthermore, despite the diversity of serotypes of Lm, only three serotypes are responsible for >90% of human disease: 1/2a, 1/2b, and 4b. The majority of strains were serotype 4b  (23 of 28 cases; 82%), suggesting that serotype 4b of Lm is more virulent than others. Otherwise, blood cultures were positive in more than half of the cases in the present series. Some reports advocate the use of the polymerase chain reaction or immunoassays for the early detection of Lm [22, 23], but these techniques need further evaluation.
Most patients in our case series received appropriated empirical therapy, 40/43 (93%), in 11 of them associated to aminoglycosides. Our study showed that a definitive combined therapy with aminoglycosides was significantly associated with an increasing trend for an unfavourable outcome and mortality, which corresponds with a previous study . These results could be explained by Lm meningitis patients have an associated co-morbid condition, in which addition of an aminoglycoside may be harmful. For this reason, actually this combined therapy is been questioned, moreover of the drug's associated nephrotoxicity and inability to cross the blood-brain barrier. In this way, every case should be approached independently, although certain subsets of patients probably require empiric antibiotic treatment for Lm, such as patients over 45-50 years of age, patients with immunosuppression, a higher CSF/blood glucose ratio, or patients with a Gram stain of CSF revealing Gram-positive bacilli , and the associated with aminoglycosides should be avoid in order to improve patient's outcome.
A significant number of patients, 5 of 31 (16.1%) of the survivors in the present series had some degree of residual neurological deficit at hospital discharge. Although an even higher incidence of residual neurological deficits (32%) was noted among survivors enrolled in 3 previous series and deficits persisted for more than a year in 4 of 10 of those cases with adequate follow up [25–27].
Moreover, mortality due to Lm is among the highest of all causes of acute bacterial meningitis . Part of the high mortality of Listeria infection may relate to the increased number of immunocompromised and older patients affected by this pathogen [29, 30]. Although evidence for use of anticonvulsant prophylaxis in Lm meningitis is lacking, it may be considered as seizures have previously been related to increases mortality , as did we in the present series, although this was not statistically significant. Further studies are needed in order to clarify this point.
Finally, the role of adjunctive therapy with corticosteroids has been widely debated. A clinical trial showed a beneficial effect of early dexamethasone treatment in adults with bacterial meningitis . Nevertheless, there are no studies on the effect of dexamethasone in adult Listeria meningitis. We observed a higher survival rate among those patients that received dexamethasone concomitant to antibiotic, although this association did not reach statistical significance. Our results suggest that further studies are needed to evaluate the effect of corticosteroid therapy in adult patients with Lm meningitis.
The present study has several limitations. First, given the small number of patients, we were unable to develop a statistical model to identify risk factors independently associated with a poor outcome or death in patients with acute community-acquired Lm meningitis. Secondly, only patients who underwent lumbar puncture and who had a positive cerebrospinal fluid culture were included. Negative cerebrospinal fluid cultures occur in 20 percent of patients with acute community acquired bacterial meningitis. Third, delay of antimicrobial therapy was not recorded. Despite all these limitations, we consider that this study contributes to our knowledge of risk factors associated with development of acute community-acquired Lm meningitis, and to evaluating epidemiology, clinical features, management, and outcome in this homogenous population of adult patients with acute community-acquired Lm meningitis.
To sum up, our study showed elderly or immunocompromised patients and a higher CSF/blood glucose ratio in patients with Ac-ABM must alert clinicians about Lm aetiology. Furthermore, we observed a high incidence of acute community-acquired Lm meningitis in adults and the addition of aminoglycosides to treatment should be avoid in order to improve the patients' outcome. Nevertheless, despite developments in intensive care and antimicrobial therapy, this entity is still a serious disease that carries high morbidity and mortality rates. Further studies should focus on specific interventions (e.g. adjuvant therapies) that could help to improve the poor prognosis of these patients.
Supported by Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III - FEDER, Spanish Network for the Research in Infectious Diseases (REIPI RD06/0008).
- Lorber B: Listeria monocytogenes. Principles and Practice of Infectious Diseases. Edited by: Mandell GL, Bennett JE, Dolin R. 2005, Philadelphia: Churchill Livingstone, 2478-2484. SixthGoogle Scholar
- Van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M: Clinical Feactures and Prognostic Factors in Adults with Bacterial Meningitis N. Engl J Med. 2004, 351: 1849-59. 10.1056/NEJMoa040845.View ArticleGoogle Scholar
- Mylonakis E, Hohmann EL, Calderwood SB: Central Nervous System infection with Listeria monocytogenes. 33 years experience at a general hospital review of 776 episodies of Literature. Medicine. 1998, 77: 313-36. 10.1097/00005792-199809000-00002.View ArticlePubMedGoogle Scholar
- Calder JAM: Listeria meningitis in adults. Lancet. 1997, 350: 307-8. 10.1016/S0140-6736(05)63384-3.View ArticlePubMedGoogle Scholar
- Zuñiga M, Aguado JM, Vado J: Listeria monocytogenes in previously healthy adults: long-term follow-up. Q J Med. 1992, 85: 911-5.PubMedGoogle Scholar
- Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV: Bacterial meningitis in the United States, 1986: Report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis. 1990, 162: 1316-23.View ArticlePubMedGoogle Scholar
- Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS, Swartz MN: Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med. 1993, 328: 21-28. 10.1056/NEJM199301073280104.View ArticlePubMedGoogle Scholar
- Hussein AS, Shafran SD: Acute bacterial meningitis in adults. A 12-year review. Medicine (Baltimore). 2000, 79: 360-368. 10.1097/00005792-200011000-00002.View ArticleGoogle Scholar
- Flores-Cordero JM, Amaya-Villar R, Rincón-Ferrari MD, Leal-Noval SR, Garnacho-Montero J, Llanos-Rodríguez AC, Murillo-Cabezas F: Acute community-acquired bacterial meningitis in adults admitted to the intensive care unit: clinical manifestations, management and prognostic factors. Intensive Care Med. 2003, 29: 1967-73. 10.1007/s00134-003-1935-4.View ArticlePubMedGoogle Scholar
- Notermans S, Chakraborty T, Leimester-Wächter M, Dufrenne J, Heuvelman KJ, Maas H, Jansen W, Wernars K, Guinee P: Specific gene probe for detection of biotyped ans serotyped Listeria strains. Appl Environ Microbiol. 1989, 55: 902-6.PubMedPubMed CentralGoogle Scholar
- Brouwer M, van de Beek D, Heckenberg SG, Spanjaard L, de Gans J: Community-acquired Listeria monocytogenes meningitis in adults. Clinical Infectious Diseases. 2006, 43: 1233-8. 10.1086/508462.View ArticlePubMedGoogle Scholar
- Brouwer MC, van de Beek D, Heckenberg SG, Spanjaard L, de Gans J: Hyponatremia in adults with community-acquired bacterial meningitis. QJM. 2007, 100 (1): 37-40. 10.1093/qjmed/hcl131.View ArticlePubMedGoogle Scholar
- Jennett B, Bond M: Assessment of outcome after brain damage. Lancet. 1975, 480-484. 10.1016/S0140-6736(75)92830-5.Google Scholar
- Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, Lefkowitz L, Perkins BA: Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med. 1997, 337: 970-976. 10.1056/NEJM199710023371404.View ArticlePubMedGoogle Scholar
- Fraser DW, Geil CC, Feldman RA: Bacterial meningitis in Bernalillo County, New Mexico: A comparison with three other American populations. Am J Epidemiol. 1974, 100: 29-34.PubMedGoogle Scholar
- Fraser DW, Henke CE, Feldman RA: Changing patterns of bacterial meningitis in Olmsted County, Minnesota, 1935-1970. J Infect Dis. 1973, 128: 300-307.View ArticlePubMedGoogle Scholar
- Pfadenhauer K, Rossmanith T: Spinal manifestation of neurolisteriosis. J Neurol. 1995, 242: 153-156. 10.1007/BF00936888.View ArticlePubMedGoogle Scholar
- Spanjaard L, Bol P, Zanen HC: Non-neonatal meningitis due to less common bacterial pathogens, the Netherlands, 1975-83. J Hyg (London). 1986, 97: 219-228. 10.1017/S002217240006530X.View ArticleGoogle Scholar
- Van de Beek D, de Gans J, Tunkel AR, Wijdicks EF: Community-acquired bacterial meningitis in adults. N Engl J Med. 2006, 354: 44-53. 10.1056/NEJMra052116.View ArticlePubMedGoogle Scholar
- Onorato IM, Wormser GP, Nicholas P: "Normal" CSF in bacterial meningitis. JAMA. 1980, 244: 1469-71. 10.1001/jama.244.13.1469.View ArticlePubMedGoogle Scholar
- Aouaj Y, Spanjaard L, Van Leeuwen N, Dankert J: Listeria monocytogenes meningitis: serotype distribution and patients characteristics in the Netherlands, 1976-95. Epidemiol Infect. 2002, 128: 405-409. 10.1017/S0950268802006969.View ArticlePubMedPubMed CentralGoogle Scholar
- Gholizadeh Y, Juvin M, Beretti JL, Berche P, Gaillard JL: Culture-negative listeriosis of the central nervous system diagnosed by detection of antibodies to listeriolysin O. Eur J Clin Microbiol Infect Dis. 1997, 16: 176-78. 10.1007/BF01709483.View ArticlePubMedGoogle Scholar
- Freeman HR, Mai NT, Diep TS, Parry C, Hien TT, Farrar JJ: The role of the polymerase chain reaction in the diagnosis of bacterial meningitis in Vietnam. Ann Trop Med Parasitol. 2004, 98: 65-70. 10.1179/000349804225003046.View ArticlePubMedGoogle Scholar
- Mitjà O, Pigrau C, Ruiz I, Vidal X, Almirante B, Planes AM, Molina I, Rodríguez D, Pahissa A: Predictors of mortality and impact of aminoglycosides on outcome in listeriosis in a retrospective cohort study. Journal of Antimicrobial Chemotherapy. 2009, 64: 416-423. 10.1093/jac/dkp180.View ArticlePubMedGoogle Scholar
- Larsson S, Cronberg S, Winblad S: Clinical aspects on 64 cases of juvenile and adult listeriosis in Sweden. Acta Med Scand. 1978, 204: 503-8. 10.1111/j.0954-6820.1978.tb08480.x.View ArticlePubMedGoogle Scholar
- Pollock SS, Pollock TM, Harrison MJ: Infection of the central nervous system by Listeria monocytogenes: A review of 54 adult and juvenile cases. Q J Med. 1984, 53: 331-40.PubMedGoogle Scholar
- Hansen PB, Jensen TH, Lykkegaard S, Kristensen HS: Listeria monocytogenes meningitis in adults. Sixteen consecutive cases 1973-1982. Scand J Infect Dis. 1987, 19: 55-60. 10.3109/00365548709032378.View ArticlePubMedGoogle Scholar
- Schlech WF, Ward JI, Band JD, Hightower A, Fraser DW, Broome CV: Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study. JAMA. 1985, 253: 1749-54. 10.1001/jama.253.12.1749.View ArticlePubMedGoogle Scholar
- Goulet V, Marchetti P: Listeriosis in 225 non-pregnant patients in 1992: Clinical aspects and outcome in relation to predisposing conditions. Scand J Infect Dis. 1996, 28: 367-74. 10.3109/00365549609037921.View ArticlePubMedGoogle Scholar
- Iwarson S, Larsson S: Outcome of Listeria monocytogenes infection in compromised and non-compromised adults, a comparative study of seventy-two cases. Infection. 1979, 7: 54-56. 10.1007/BF01641612.View ArticlePubMedGoogle Scholar
- Bouvet E, Suter F, Gibert C, Witchitz JL, Bazin C, Vachon F: Severe meningitis due to Listeria monocytogenes. A review of 40 cases in adults. Scand J Infect Dis. 1982, 14: 267-70.View ArticlePubMedGoogle Scholar
- De Gans J, van de Beek D: Dexamethasone in adults with bacterial meningits. N Engl J Med. 2002, 347: 1549-56. 10.1056/NEJMoa021334.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/10/324/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.